Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease

Ting Zhang1, Prashant Mishra2, Bruce A Hay2

  • 1Department of Neurology, UCLA David Geffen School of Medicine, University of California, Los Angele, United States.

Elife
|March 22, 2017
PubMed

Insights

Missense mutations in valosin-containing protein (VCP) cause IBMPFD. VCP inhibitors show therapeutic potential by suppressing mitochondrial defects and muscle damage in IBMPFD models.

Area of Science:

  • Cell Biology
  • Neurodegenerative Diseases
  • Mitochondrial Biology

Background:

  • Missense mutations in valosin-containing protein (VCP) are linked to inclusion body myopathy, Paget disease with frontotemporal dementia (IBMPFD) and other neurodegenerative disorders.
  • The precise pathological mechanisms underlying IBMPFD remain unclear, and effective treatments are currently unavailable.

Purpose of the Study:

  • To investigate the role of VCP in mitochondrial dynamics and explore potential therapeutic strategies for IBMPFD.
  • To establish and utilize an in vivo Drosophila model of IBMPFD to study disease pathology and test therapeutic interventions.

Main Methods:

  • Utilized an adult Drosophila muscle model to recapitulate IBMPFD pathologies.
  • Investigated the interaction between VCP and Mitofusin, a key regulator of mitochondrial outer membrane fusion.
  • Assessed the efficacy of VCP inhibitors in Drosophila models and patient-derived fibroblasts.

Main Results:

  • Endogenous VCP negatively regulates Mitofusin, essential for mitochondrial fusion.
  • Common VCP disease mutants function as hyperactive alleles, disrupting Mitofusin regulation.
  • VCP inhibitors effectively suppressed mitochondrial defects, muscle damage, and cell death in Drosophila models.
  • Inhibitors also ameliorated mitochondrial fusion and respiratory deficits in IBMPFD patient fibroblasts.

Conclusions:

  • VCP disease mutants likely cause IBMPFD through a gain-of-function mechanism.
  • VCP inhibitors demonstrate significant therapeutic potential for treating IBMPFD and related mitochondrial disorders.

Related Concept Videos

Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
3.9K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
5.9K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.8K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.6K
Porin Insertion in the Outer Mitochondrial Membrane01:12

Porin Insertion in the Outer Mitochondrial Membrane

Porins are beta-barrel proteins translocated to the mitochondrial outer membrane through the TOM complex into the intermembrane space. Porin precursors bind TIM chaperones within the intermembrane space and are guided to the Sorting and Assembly Machinery complex or SAM complex on the outer mitochondrial membrane.
Three models describe the assembly of porins by the SAM complex and their insertion into the outer membrane. Model 1 suggests that porins are assembled outside the SAM channel as the...
5.0K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.5K